The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Antibody therapy

Antibody therapy

Monoclonal antibodies target antigens expressed by lymphoma cells, making them more selective than chemotherapy. As exemplified by rituximab, which targets CD20 present on B-cells, the Fc portion of the antibody mediates cytotoxicity, while the binding site induces downregulation of the B-cell receptor and apoptosis in CD20+ cells. 

|||

All Interventions